Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H21NO2 |
Molecular Weight | 247.3327 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]1(CCCCN1)[C@H](C(=O)OC)C2=CC=C(C)C=C2
InChI
InChIKey=WJZNCJIOIACDBR-UONOGXRCSA-N
InChI=1S/C15H21NO2/c1-11-6-8-12(9-7-11)14(15(17)18-2)13-5-3-4-10-16-13/h6-9,13-14,16H,3-5,10H2,1-2H3/t13-,14+/m0/s1
Molecular Formula | C15H21NO2 |
Molecular Weight | 247.3327 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:35:48 GMT 2023
by
admin
on
Sat Dec 16 10:35:48 GMT 2023
|
Record UNII |
1Y11XUO4EY
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-4-Methylmethylphenidate
Created by
admin on Sat Dec 16 10:35:48 GMT 2023 , Edited by admin on Sat Dec 16 10:35:48 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1Y11XUO4EY
Created by
admin on Sat Dec 16 10:35:48 GMT 2023 , Edited by admin on Sat Dec 16 10:35:48 GMT 2023
|
PRIMARY | |||
|
191790-79-1
Created by
admin on Sat Dec 16 10:35:48 GMT 2023 , Edited by admin on Sat Dec 16 10:35:48 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
4-MMPH
Created by
admin on Sat Dec 16 10:35:48 GMT 2023 , Edited by admin on Sat Dec 16 10:35:48 GMT 2023
|
PRIMARY | This appears to be the first new phenidate in the UK after the EPH, PPH, IPH, 3,4-CTMP and HDMP-28 ban. I've tried it a few times myself at 25-80mg oral, and from my experience it's the closest RC phenidate to Methylphenidate so far. Very similar duration, a little less potent. | ||
|
467468-40-2
Created by
admin on Sat Dec 16 10:35:48 GMT 2023 , Edited by admin on Sat Dec 16 10:35:48 GMT 2023
|
PRIMARY | |||
|
DTXSID601029380
Created by
admin on Sat Dec 16 10:35:48 GMT 2023 , Edited by admin on Sat Dec 16 10:35:48 GMT 2023
|
PRIMARY | |||
|
4-Methylmethylphenidate
Created by
admin on Sat Dec 16 10:35:48 GMT 2023 , Edited by admin on Sat Dec 16 10:35:48 GMT 2023
|
PRIMARY | threo-4-Methylmethylphenidate (4-MeTMP) is a stimulant drug related to methylphenidate. It is slightly less potent than methylphenidate and has relatively low efficacy at blocking dopamine reuptake despite its high binding affinity, which led to its investigation as a possible substitute drug for treatment of stimulant abuse (cf. nocaine). On the other hand, several other simple ring-substituted derivatives of threo-methylphenidate such as the 4-fluoro and 3-chloro compounds are more potent than methylphenidate both in efficacy as dopamine reuptake inhibitors and in animal drug discrimination assays. | ||
|
23815457
Created by
admin on Sat Dec 16 10:35:48 GMT 2023 , Edited by admin on Sat Dec 16 10:35:48 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|